Notice2021-27992
National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 27, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 245 (Monday, December 27, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 245 (Monday, December 27, 2021)]
[Notices]
[Page 73304]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-27992]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel HHS-NIH-CDC-SBIR PHS 2022-1 Phase
II: Development of monoclonal antibody-mediated interventions to
combat malaria (Topic 109).
Date: January 19, 2022.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G74,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Hailey Weerts, Scientific Review Program,
Division of Extramural Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, Room 3G74, Rockville, MD 20852, (240) 669-5931,
<a href="/cdn-cgi/l/email-protection#7a0d1f1f080e09120a3a14131b131e54141312541d150c"><span class="__cf_email__" data-cfemail="5b2c3e3e292f28332b1b35323a323f75353233753c342d">[email protected]</span></a>.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel HHS-NIH-CDC-SBIR PHS 2022-1 Phase I:
Development of monoclonal antibody-mediated interventions to combat
malaria (Topic 109).
Date: January 19, 2022.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G74,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Hailey Weerts, Scientific Review Program,
Division of Extramural Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, Room 3G74, Rockville, MD 20852, (240) 669-5931,
<a href="/cdn-cgi/l/email-protection#354250504741465d45755b5c545c511b5b5c5d1b525a43"><span class="__cf_email__" data-cfemail="9aedffffe8eee9f2eadaf4f3fbf3feb4f4f3f2b4fdf5ec">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS).
Dated: December 20, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-27992 Filed 12-23-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 27, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.